Research and News Involving:
Oncology
Adult, Brigham Young University, Current Research, Dr. Watt, Drug, Oncology, Rare Disease
Treating Anemia in Myelofibrosis with Nelfinavir Principal Investigator: Dr. Richard Watt Disease: Myelofibrosis Research Description: Patients with myelofibrosis, an incurable blood cancer, often have chronic inflammation, which results in high levels of the hormone...
Adult, City of Hope, Current Research, Dr. Phillips, Drug, Health Equity, Los Angeles, Oncology, Rare Disease
Repurposing Venetoclax and Glofitamab to Improve Patient Response in Mantle Cell Lymphoma Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is...
Adult, Dr. Romancik, Drug, Emory University, Ended Early, Oncology, Rare Disease
Combining Approved Drugs for Alcoholism and Cancer to Treat Diffuse Large B-cell Lymphoma Principal Investigator: Dr. Jason Romancik Disease: Diffuse Large B-cell Lymphoma Research Description: Diffuse large B-cell lymphoma (DLBCL) and other aggressive subtypes of...
Brown University, CureAccelerator Live!, Dr. Holder, Drug, Ended Early, Health Equity, Oncology, Rhode Island Hospital
Repurposing the Prostate Cancer Drug Degarelix to Treat Bladder Cancer Principal Investigator: Dr. Sheldon Holder Condition: Bladder Cancer Research Description: More than 80,000 people are diagnosed with bladder cancer (BC) in the USA each year and roughly 17,000...
Adult, Completed Research, Dr. Ito, Drug, Oncology, Rare Disease, University of Pittsburgh
Investigating a Rare Disease Drug to Treat AML and MDS Patients with Post-Stem Cell Transplant Relapse Principal Investigator: Dr. Sawa Ito Disease: Acute Myeloid Leukemia and Myelodysplastic Syndrome Research Description: Allogeneic hematopoietic stem cell...
Current Research, Dr. Ohanian, Drug, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Adding Metal Detoxification Drugs to Improve Childhood AML and Other Blood Cancer Outcomes Principal Investigator: Dr. Maro Ohanian Disease: Pediatric, adolescent and young adult Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia...
Adult, Chicago, Completed Research, Device, Diagnostic, Dr. Sims, Health Disparities, Health Equity, Oncology, Rare Disease, University of Illinois at Chicago
Repurposing a Diagnostic Device to Address Health Disparities in Esophageal Cancer Screening and Outcomes Principal Investigator: Dr. H. Steven Sims Disease: Esophageal cancer Research Description: Esophageal cancer can be divided into two types: adenocarcinoma (the...
Adult, Current Research, Dr. Ntekim, Drug, Health Equity, LMICs, Oncology, Rare Disease, ReGRoW, University College Hospital Ibadan, Women's Health
Adding the Antibiotic Clofazimine to Chemotherapy for Triple Negative Breast Cancer in Nigeria Principal Investigator: Dr. Atara Ntekim Disease: Breast cancer Research Description: Breast cancer causes high cancer related death globally. A type called triple negative...
Completed Research, CureAccelerator Live!, Dr. Gordon, Drug, Health Equity, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Adult, Chicago, CureAccelerator Live!, Current Research, Drug, Loyola University Medical Center, Oncology, Rare Disease, Women's Health
Repurposing the Blood Pressure Drug Minoxidil for the Treatment of Recurrent Chemo-Resistant Ovarian and Other Gynecological Cancers Principal Investigator: Dr. Margaret Liotta Disease: Ovarian cancer Research Description: Epithelial ovarian cancer is the most lethal...
Combo, Drug, Oncology, Pre-clinical, Prof. Allen, Rare Disease, University of Cambridge
Testing two generic drugs to improve outcomes in osteosarcoma, a rare bone cancer Principal Investigator: Prof. Matthew Allen Disease: Osteosarcoma Research Description: Although osteosarcoma (OSA) is a rare type of cancer, it is the most common bone cancer in...
Adult, CureAccelerator Live!, Dr. Phillips, Drug, Health Equity, Oncology, Rare Disease, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
Children's Hospital of Philadelphia, Current Research, Diagnostic, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease
Preventing Relapse After Bone Marrow Transplant in Pediatric Acute Lymphoblastic Leukemia with a Personalized Treatment Principal Investigator: Dr. Alix Seif Disease: Acute Lymphoblastic Leukemia Research Description: Pediatric acute lymphoblastic leukemia (ALL)...
Adult, CureAccelerator Live!, Current Research, Dr. Fleischman, Drug, Los Angeles, Oncology, Rare Disease, University of California, University of California Irvine
Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with N-Acetylcysteine Principal Investigator: Dr. Angela Fleischman Disease: Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia and myelofibrosis Research Description:...
Completed Research, Dr. Riggins, Drug, Johns Hopkins Medicine, Mid-Atlantic, Oncology, Pediatric, Rare Disease
A Phase I Trial for Recurrent Pediatric Brain Cancers Using a Repurposed Generic Drug Principal Investigator: Dr. Gregory Riggins Disease: Medulloblastoma, Glioblastoma Research Description: Medulloblastoma is the most common malignant brain tumor in children, and...
Adult, Completed Research, Device, Dr. Davalos, Dr. Martin, Mid-Atlantic, Oncology, Rare Disease, Virginia Tech University
Using an Approved Device to Increase the Immune Response in Pancreatic Cancer Patients Principal Investigator: Dr. Rafael Davalos Co-Investigator: Dr. Robert C.G. Martin Disease: Pancreatic Cancer Research Description: Irreversible electroporation (IRE) is a...
Completed Research, Dr. Leary, Drug, Oncology, Pediatric, Rare Disease, Seattle Children's
Repurposing Drugs for Recurrent Pediatric Brain Tumors Principal Investigator: Dr. Sarah Leary Disease: Pediatric Brain Cancer Research Description: Pediatric brain tumors are the most common solid tumor malignancy in children, and continue to be a leading cause of...
Adult, Chicago, Completed Research, Diagnostic, Dr. Borgia, Oncology, Rush University Medical Center
Repurposing a blood test to improve outcomes for high-risk lung cancer patients undergoing low-dose CT screening Principal Investigator: Dr. Jeffrey Borgia Disease: Lung Cancer Research Description: Early detection of lung cancer can save lives. Low‐dose computer...
Adult, Completed Research, CureAccelerator Live!, Dr. Swiecicki, Drug, Longest Day of Golf, Oncology, Rare Disease, University of Michigan
Repurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer Principal Investigator: Dr. Paul Swiecicki Disease: Thyroid Cancer Research Description: Thyroid cancer is the sixteenth most common malignancy in the world. Although most patients are cured with a...
Adult, Dr. Pettit, Drug, Oncology, Rare Disease, University of Michigan
Using a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer, Myelofibrosis Principal Investigator: Dr. Kristen Pettit Disease: Myelofibrosis Research Description: Myelofibrosis (MF) is a rare, aggressive bone marrow cancer causing excessive scar...
